Skip to content

Evaluation of the efficacy of a new meibomian gland massage device

Evaluation of the efficacy of a new meibomian gland massage device

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500098716
Enrollment
Unknown
Registered
2025-03-12
Start date
2024-04-17
Completion date
Unknown
Last updated
2025-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meibomian gland dysfunction

Interventions

new meibomian gland massage device test group:meibomian gland massage
new meibomian gland massage device blank control group:use eye drops
meibomian gland massage forceps test group:meibomian gland massage
meibomian gland massage forceps blank control group:use eye drops

Sponsors

Eye Hospital, Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.age >=16 years old; 2.diagnosis of moderate to severe obstructive meibomian gland dysfunction.

Exclusion criteria

Exclusion criteria: 1.loss of meibomian glands>2/3; 2.abnormal eyelid structure; 3.active ocular inflammation or other eye diseases such as glaucoma and punctale occlusion; 4.history of ocular surgery or trauma; 5.wearing contact lenses within the past 2 weeks; 6.receiving relevant physical therapy or intense pulsed light therapy within the past 6 months; 7.long-term ocular medications; 8.autoimmune disease requiring systemic treatment; 9.pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
the degree of blockage of the meibomian gland openings;the meibum quality;the meibum expressibility;

Secondary

MeasureTime frame
scores of OSDI;scores of SPEED;tear meniscus height;non-invasive tear break-up time;lipid layer thickness;Fluorescein-stained tear film break-up time;corneal ?uorescein staining;Eyelid margin;loss of meibomian glands;

Countries

China

Contacts

Public ContactZelin Zhao

Eye Hospital, Wenzhou Medical University

zhaozelinwz@qq.com+86 135 8786 6512

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026